Institutional shares held 45.2 Million
48.3K calls
30.7K puts
Total value of holdings $1.59B
$1.7M calls
$1.08M puts
Market Cap $1.56B
44,288,800 Shares Out.
Institutional ownership 101.98%
# of Institutions 282


Latest Institutional Activity in OMCL

Top Purchases

Q3 2025
Millennium Management LLC Shares Held: 842K ($29.6M)
Q3 2025
Cadian Capital Management, LP Shares Held: 2.09M ($73.5M)
Q3 2025
Acadian Asset Management LLC Shares Held: 513K ($18M)
Q3 2025
Two Sigma Investments, LP Shares Held: 560K ($19.7M)
Q3 2025
Dimensional Fund Advisors LP Shares Held: 2.36M ($83M)

Top Sells

Q3 2025
Victory Capital Management Inc Shares Held: 141K ($4.94M)
Q3 2025
Citadel Advisors LLC Shares Held: 300K ($10.6M)
Q3 2025
Macquarie Group LTD Shares Held: 764K ($26.8M)
Q3 2025
Barclays PLC Shares Held: 99.9K ($3.51M)
Q3 2025
D. E. Shaw & Co., Inc. Shares Held: 1.14M ($40.1M)

About OMCL

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.


Insider Transactions at OMCL

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
585K Shares
From 16 Insiders
Grant, award, or other acquisition 546K shares
Exercise of conversion of derivative security 28.3K shares
Open market or private purchase 10.6K shares
Sell / Disposition
143K Shares
From 7 Insiders
Payment of exercise price or tax liability 101K shares
Open market or private sale 41.7K shares

Track Institutional and Insider Activities on OMCL

Follow OMNICELL, Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OMCL shares.

Notify only if

Insider Trading

Get notified when an Omnicell, Inc insider buys or sells OMCL shares.

Notify only if

News

Receive news related to OMNICELL, Inc

Track Activities on OMCL